Rhythm Pharmaceuticals Inc
RYTM
NASDAQ
Biotechnology
$115.48
USD
-0.54 (-0.47%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.14B
Volume 334.9K
Price Target
$145.00 – $155.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $155.00 and a min estimate of $145.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$150.33
+$11.9 vs prior
Implied Upside
+30.2%
+10.3% vs prior
Analyst Covering
3
-7 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
23%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0.6700 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Priyanka Grover | JP Morgan | Buy | Initiated | 2 weeks ago | Plus | Plus | Plus |
Whitney Ijem | Canaccord Genuity | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Derek Archila | Wells Fargo | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
